Home » Usa limit Johnson & Johnson vaccine use, thrombosis risk

Usa limit Johnson & Johnson vaccine use, thrombosis risk

by admin
Usa limit Johnson & Johnson vaccine use, thrombosis risk

Out of approximately 19 million doses of Johnson & Johnson administered in the US, 60 cases of thrombosis have been detected, of which 9 are fatal. For this reason, the American FDA has announced that it will limit the use of the vaccine against Covid Johnson & Johnson due to the risk of “rare but serious thrombosis”. For the same reason, the CDC, since December the American Center for Disease Control, has recommended using Pfizer and Moderna, instead of Johnson & Johnson. The vaccine may henceforth be used only for adults who reject Pfizer or Moderna “for personal reasons” or who cannot receive them.

See also  Gérard Depardieu affair: Miou-Miou reveals his feelings: “It’s not possible that…”

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy